AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ArcticZymes Technologies Director's Dealing 2018

May 16, 2018

Director's Dealing

Opens in your device viewer

Biotec Pharmacon - Mandatory notification of trade

(Tromsø 16. May 2018) Rolf E. Engstad, CSO of Biotec BetaGlucans has today

purchased 20 000 shares in Biotec Pharmacon at NOK 6.40 per share. After this

transaction holds Engstad 410.774 shares and 80.000 options in Biotec Pharmacon

For further information, please contact

Børge Sørvoll

CFO

+47 952 90 187